- category:Business
Business
Eyenovia proposes merger with Betaliq to form glaucoma company
Potential deal would result in a new glaucoma-focused company combining the EyeSol water-free drug delivery tech and Optejet device platform.Business
AAO adds ERG to preferred practice guidelines for DR
Gold standard for clinical decision-making promotes electroretinography, enabling earlier intervention and personalized care.Business
Alcon to acquire Lensar and its next-gen FLACS portfolio
Deal includes the ALLY Robotic Cataract Laser System, the first FDA-cleared platform to enable femtosecond-laser-assisted cataract surgery.Business
Lighthouse Guild selects accessibility innovator as new leader
President and CEO of Guiding Eyes for the Blind Thomas Panek will take the helm starting next month.Business
Tenpoint Therapeutics names veteran executive as first CCO
Carol Kearney to lead company’s efforts to launch and expand global availability of BRIMOCHOL PF for presbyopia.Business
Foundation Fighting Blindness appoints new chief scientific officer
Amy Laster, PhD, is spearheading the organization’s 5-year strategic plan as the organization plans to host a free IRD-based webinar on March 13.Business
Staar Surgical appoints new CEO amid leadership changes
Global healthcare executive veteran Stephen C. Farrell takes over the helm as Elizabeth Yeu, MD, is named board chair of STAAR’s Board of Directors.Business
TECLens raises $9.3M in funding for non-invasive refractive tech
The company's corneal CXL-based, non-incisional refractive correction procedure is designed to reshape the corneal for presbyopes and myopes.Business
CooperVision announces myopia management updates and plans
Company creates new position of Vice President, Myopia Management & Cornea Care and previews clinical investigation plans.Business
Iantrek names former Trukera Medical leader as new CEO
Adam Szaronos joins the biotechnology company as it plans a full commercial launch of two surgical glaucoma devices later this year.Business
CooperVision names new leader of Americas division
Thirty-year consumer healthcare veteran Steven Robins is assuming the role of president, Americas.Business
Harrow partners with Cencora to launch product accessibility program
Harrow Cares program to ensure efficient enrollment, rapid therapy access, and personalized support for retina providers adding IHEEZO and TRIESENCE to practices.Business
Bausch + Lomb may be acquiring InflammX Therapeutics
Option agreement indicates B+L intends to purchase the biotech company and its orally-administered therapeutic under clinical investigation for retinal diseases.Business
HelpMeSee expanding simulation-based surgical training to two new locations
New training sites in Los Angeles and Chicago will offer four categories of on-demand learning and hands-on experience in a safe, repeatable, and realistic environment.Business
VisiRose raises $3M to advance RB-PDAT therapeutic toward regulatory approval
Funding will support ongoing clinical development of photodynamic therapy candidate for infectious keratitis and future IND submission to FDA.Business
WAVE Eye Care launches as new specialty contact lens division
EyePrint Prosthetics, Advanced Vision Technologies, and WAVE Contact Lens System join forces to offer unique and customized specialty contact lens offerings.Business
Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.Business
Aviceda raises $207M to support phase 3 testing of AVD-104 for GA
Financing will support advancement of AVD-104, designed to target a specific area of the innate immune response relating to AMD.Business
Regeneron reportedly purchases British biotech Oxular
Announcement made by CEO seemingly confirms acquisition of the retinal disease company and its lead candidate: OXU-001, a sustained-release dexamethasone formulation for DME.Business